ASC proposed fees add corneal implant to device-intensive list

Why This Topic Matters

ASC payment methodology can affect where ophthalmic procedures are performed and how facilities are reimbursed, especially when implants are involved. Understanding the proposal helps readers assess reimbursement impact, operational planning, and the relationship between ASC and hospital outpatient payment structures.

Article Sections

1. Proposed ASC payment change for ophthalmology implants

   Summarizes the proposed rule discussed in the article and its focus on an ophthalmic implant being added to the device-intensive list. It introduces the payment context for ASCs and hospital outpatient departments.

2. Transition formula

   Describes the broader ASC transition payment framework and why it is relevant to ophthalmology services. The section addresses the operational concerns that arise when facilities compare ASC and hospital outpatient reimbursement levels.

3. Effect on implants

   Explains the article’s discussion of implant-inclusive payment policy under the ASC system and how it relates to device-intensive procedures. It also references the early years of the payment transition and its effect on reimbursement structure.

4. Official resources

   Lists CMS and Federal Register reference sources cited by the article. These resources provide background documentation and related payment-system information.

5. 2008 vs 2009 ASC fees

   Presents a comparative table of ophthalmology ASC facility fees for selected procedures across two years. The table is intended as a reimbursement overview rather than a clinical discussion.